Bank Of Montreal Neurocrine Biosciences Inc Transaction History

Bank Of Montreal

$192 Billion
Q1 2025

A detailed history of Bank Of Montreal transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Bank Of Montreal holds 32,705 shares of NBIX stock, worth $4.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,705

Previous 35,094 6.81%

Holding current value

$4.19 Million

Previous $4.79 Million 24.49%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$107.22 - $153.29 $256,148 - $366,209	-2,389 Reduced 6.81%	32,705 $3.62 Million
Q4 2024 Feb 13, 2025	SELL	$111.62 - $139.44 $2.25 Million - $2.81 Million	-20,150 Reduced 36.47%	35,094 $4.79 Million
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $1.82 Million - $2.43 Million	15,893 Added 40.39%	55,244 $6.36 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $275,067 - $300,985	2,102 Added 5.64%	39,351 $5.42 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $1.1 Million - $1.21 Million	-8,414 Reduced 18.43%	37,249 $5.14 Million
Q4 2023 Feb 08, 2024	SELL	$106.07 - $132.76 $11.5 Million - $14.4 Million	-108,729 Reduced 70.42%	45,663 $6.02 Million
Q3 2023 Nov 01, 2023	SELL	$94.02 - $117.1 $12 Million - $15 Million	-127,769 Reduced 45.28%	154,392 $17.4 Million
Q2 2023 Aug 02, 2023	BUY	$89.53 - $104.87 $20 Million - $23.4 Million	223,061 Added 377.43%	282,161 $26.6 Million
Q1 2023 Jun 13, 2024	BUY	$94.11 - $123.02 $2.81 Million - $3.68 Million	29,889 Added 80.24%	67,138 $6.8 Million
Q4 2022 Feb 01, 2023	BUY	$106.72 - $127.06 $6,723 - $8,004	63 Added 0.11%	59,100 $7.06 Million
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $4.43 Million - $5.19 Million	48,143 Added 441.92%	59,037 $6.3 Million
Q2 2022 Aug 11, 2022	SELL	$75.79 - $100.07 $5.45 Million - $7.19 Million	-71,849 Reduced 86.83%	10,894 $1.07 Million
Q1 2022 May 12, 2022	SELL	$72.45 - $94.81 $2.03 Million - $2.66 Million	-28,078 Reduced 25.34%	82,743 $7.67 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $50.7 Million - $67.6 Million	-636,419 Reduced 85.17%	110,821 $9.41 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $33.2 Million - $38.2 Million	385,781 Added 106.73%	747,240 $71.1 Million
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $32.3 Million - $37 Million	361,459 New	361,459 $36.2 Million

Others Institutions Holding NBIX

# of Institutions

649

Shares Held

97.6M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account